GlassScriptPhysician profile
Malik Ahmed
NPI 1386165470
$3,688.31
in general payments reported to CMS, 2019-2025
9 companies · $2,078 in 2025
The $2,078 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.00 · 2022: $21.98 · 2023: $241 · 2024: $1,249 · 2025: $2,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,187 · Food and Beverage: $1,291 · Education: $89.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,187.18 |
| Food and Beverage | $1,290.95 |
| Education | $89.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,350.65 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abbott Laboratories | $941.66 | 2024-2025 | Aveir, Triclip, Portico |
| Astrazeneca Pharmaceuticals LP | $124.27 | 2021-2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.20 | 2023 | Lifevest |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
| Heartflow, INC. | $34.35 | 2023 | Ffrct |
| Abiomed | $32.58 | 2023 | Impella |
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Pfizer INC. | $21.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malik Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.